Last, in 3 studies included in Su et al.’s meta-analysis, TIMP2 IGFBP7 has been analyzed only for the detection of stage 2–3 CS-AKI [9] and in most other studies, stage 2–3 CS-AKI featured prominently among cases of CS-AKI. This evidence concerns the gene TIMP2 and acute kidney injury.